About the event

Held over a weekend, the event is structured around a series of exhibitions, workshops, and panel discussions. The exhibitions showcase a curated selection of photographs that tell compelling stories from various corners of the globe, each image accompanied by detailed narratives that provide context and deeper insight into the historical significance of the scenes depicted. These photographs are drawn from the archives of renowned photographers, as well as emerging talents, ensuring a blend of both classical and contemporary perspectives.

Cliff Palace, Colorado
Closing Bell Recap: Pyxis Oncology Inc (PYXS) Ends at $3.91, Reflecting a 0.26% Upturn – DwinneX

Closing Bell Recap: Pyxis Oncology Inc (PYXS) Ends at $3.91, Reflecting a 0.26% Upturn

Abby Carey

Those aiming for above-average market returns often engage in the meticulous process of stock picking. Choosing the right stocks can make a substantial difference in your wealth.

Pyxis Oncology Inc (NASDAQ: PYXS) closed the day trading at $3.91 up 0.26% from the previous closing price of $3.9. In other words, the price has increased by $0.26 from its previous closing price. On the day, 0.79 million shares were traded. PYXS stock price reached its highest trading level at $4.02 during the session, while it also had its lowest trading level at $3.84.

Ratios:

For a better understanding of PYXS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.29 and its Current Ratio is at 4.29. In the meantime, Its Debt-to-Equity ratio is 0.28 whereas as Long-Term Debt/Eq ratio is at 0.25.

On September 04, 2025, Guggenheim started tracking the stock assigning a Buy rating and target price of $5.

Insider Transactions:

The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Apr 21 ’25 when HUMPHREY RACHEL bought 13,896 shares for $1.03 per share.

HUMPHREY RACHEL bought 200 shares of PYXS for $194 on Apr 17 ’25. On Apr 14 ’25, another insider, HUMPHREY RACHEL, who serves as the Director of the company, bought 1,400 shares for $0.97 each.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PYXS now has a Market Capitalization of 243453088 and an Enterprise Value of 166807088. For the stock, the TTM Price-to-Sale (P/S) ratio is 86.33 while its Price-to-Book (P/B) ratio in mrq is 3.53. Its current Enterprise Value per Revenue stands at 59.151 whereas that against EBITDA is -2.071.

Stock Price History:

The Beta on a monthly basis for PYXS is 1.39, which has changed by -0.01015228 over the last 52 weeks, in comparison to a change of 0.13367426 over the same period for the S&P500. Over the past 52 weeks, PYXS has reached a high of $5.39, while it has fallen to a 52-week low of $0.83. The 50-Day Moving Average of the stock is 48.99%, while the 200-Day Moving Average is calculated to be 153.25%.

Shares Statistics:

Over the past 3-months, PYXS traded about 754.91K shares per day on average, while over the past 10 days, PYXS traded about 731870 shares per day. A total of 62.15M shares are outstanding, with a floating share count of 47.43M. Insiders hold about 23.83% of the company’s shares, while institutions hold 34.23% stake in the company. Shares short for PYXS as of 1760486400 were 4250799 with a Short Ratio of 5.63, compared to 1757894400 on 4359697. Therefore, it implies a Short% of Shares Outstanding of 4250799 and a Short% of Float of 8.3000004.

Earnings Estimates

The company has 7.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.3, with high estimates of -$0.23 and low estimates of -$0.42.

Analysts are recommending an EPS of between -$1.26 and -$1.36 for the fiscal current year, implying an average EPS of -$1.3. EPS for the following year is -$1.16, with 8.0 analysts recommending between -$0.78 and -$1.54.

DwinneX
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.